Related Experiment Video
Updated: Jun 17, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
[Antiplatelet therapy and urgent surgical procedures. Acute appendicitis two days after stent implantation--a case
Janusz Sielski1, Paweł Wałek, Anna Polewczyk
1Swietokrzyskie Centrum Kardiologii, Kielce, Poland.
Insights
Discontinuing antiplatelet therapy after coronary stent implantation increases stent thrombosis risk, especially with early non-cardiac surgery. Balancing bleeding and cardiovascular risks is crucial for patient management.
Area of Science:
- Cardiology
- Vascular Surgery
- Pharmacology
Background:
- Antiplatelet therapy is standard for cardiovascular prophylaxis.
- Perioperative coronary stent thrombosis is a severe complication.
- Discontinuation of antiplatelet treatment is a primary cause of stent thrombosis.
Observation:
- A 60-year-old male underwent abdominal surgery two days post-bare-metal stent implantation.
- This case highlights the challenges in managing antiplatelet therapy around non-cardiac surgery.
- Early non-cardiac surgery significantly elevates the risk of stent thrombosis.
Findings:
- Non-cardiac surgery performed soon after stent implantation increases thrombosis risk.
- Balancing antiplatelet therapy's bleeding risk against its cardiovascular protective benefits is critical.
- The timing of non-cardiac surgery relative to stent implantation is a key factor.
Implications:
- Careful consideration is needed for continuing or stopping antiplatelet therapy during non-cardiac surgery.
- Optimal perioperative management strategies are essential to prevent stent thrombosis.
- Further research into managing antiplatelet therapy in high-risk surgical patients is warranted.
Abstract:
Antiplatelet therapy has become a standard primary and secondary prophylaxis regiment in cardiology. Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients with both bare-metal or drug-eluting stents. The most important reason of this complication is discontinuation of antiplatelet treatment. Non-cardiac surgery increase the risk of stent thrombosis, especially when it is performed early after implantation of stent. Since antiplatelet therapy increases the risk of bleeding but decreases the risk of cardio-vascular events, it is very important to consider whether to stop or to continue this therapy. A case of 60-year-old male patient who underwent abdominal operation 2 days after bare-metal stent implantation is reported. Problems with correct treatment are discussed.
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Appendicitis
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: